Sequencing anti-BCMA therapies in myeloma
Blood
.
2023 Jan 19;141(3):211-212.
doi: 10.1182/blood.2022018157.
Authors
Jean-Luc Harousseau
1
,
Mohamad Mohty
2
Affiliations
1
Institut de Cancérologie de l'Ouest.
2
Sorbonne Université.
PMID:
36656612
DOI:
10.1182/blood.2022018157
No abstract available
Publication types
Editorial
Comment
MeSH terms
Humans
Immunotherapy, Adoptive
Multiple Myeloma* / drug therapy
Multiple Myeloma* / genetics
Receptors, Chimeric Antigen*
Substances
Receptors, Chimeric Antigen